Here are three quick notes:
1. The Cowen and Company 36th Annual Health Care Conference will take place on March 7 and run through March 9 in Boston.
2. The Future Leaders in the Biotech Industry Conference will take place on March 11 in New York City.
3. Innovate Biopharmaceuticals is a clinical stage biotechnology company focused on developing gastroenterology medicines. Innovate’s lead drug candidate, INN-202, is an oral peptide that has been shown to reduce clinical symptoms of celiac disease in multiple clinical trials testing more than 800 patients.
More articles on GI & endoscopy:
FDA to examine TOPAS System as treatment for female fecal incontinence — 5 things to know
GI physician leader to know: Dr. John Cello of UCSF Medical Center
Mayo Clinic to live-stream a colonoscopy to raise CRC screening awareness: 3 points’
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
